Key result
Colorectal cancer exhibits progressively lower TIMP-3 protein, dropping ~55% in advanced stages versus normal mucosa.
Why the study?
The balance between matrix metalloproteinases and tissue inhibitor of metalloproteinases is believed to play a key role in tumor invasion and metastases, but tissue inhibitor of metalloproteinase-3 expression in human colorectal cancer was not fully characterized.
Observational (n=39)
TIMP-3 protein levels are significantly decreased in human colorectal cancer compared to normal mucosa and progressively decrease with advancing tumor stage.
Answers are grounded in this paper and cite their sources.
May indicate TIMP-3 as progression marker in colorectal cancer; hypothesis-generating, requires prospective validation.
PURPOSE: The balance between local levels of matrix metalloproteinases and tissue inhibitor of metalloproteinases is believed to play a key role in tumor invasion and metastases. Because tissue inhibitor of metalloproteinase-3 suppresses tumorigenicity and tumor invasion in vitro, the aim of this study was to determine its expression in human colorectal cancer. METHODS: Thirty-nine human colorectal cancer specimens, three adenomas, and matched normal adjacent mucosa from 39 colorectal cancer patients were analyzed. Tissue inhibitor of metalloproteinase-3 ribonucleic acid and protein expression were analyzed by Northern blot hybridization and Western blot analysis, respectively. The cellular localizations of tissue inhibitor of metalloproteinase-3 ribonucleic acid and protein were determined by in situ hybridization and immunolocalization. RESULTS: Tissue inhibitor of metalloproteinase-3 ribonucleic acid expression was increased in colorectal cancer compared with paired normal mucosa. In contrast, tissue inhibitor of metalloproteinase-3 protein level was higher in normal mucosa than in the corresponding colorectal cancer. In addition, tissue inhibitor of metalloproteinase-3 protein levels progressively decreased with advancing colorectal cancer stages. Tissue inhibitor of metalloproteinase-3 protein tumor to normal mucosa ratio was 0.74 +/- 0.12, 0.51 +/- 0.18, 0.48 +/- 0.12, and 0.45 +/- 0.2 for Dukes A (n = 8), B (n = 9), C (n = 9), and D (n = 13) stages, respectively. Both tissue inhibitor of metalloproteinase-3 messenger ribonucleic acid and protein were located predominantly within spindle-shaped and round stromal cells. Furthermore, in colonic epithelium, tissue inhibitor of metalloproteinase-3 and type IV collagen protein were similarly concentrated in the basal region. CONCLUSIONS: These data provide the first detailed description of the cellular expression of tissue inhibitor of metalloproteinase-3 in colorectal cancer and identify it as a basement membrane-associated protein. This is an important observation, because the presence of tissue inhibitor of metalloproteinase-3 protein near the basement membrane supports its role in preventing proteolytic degradation, angiogenesis, and apoptosis.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2001) conducted an observational in Colorectal cancer (n=39). Colorectal cancer vs. Matched normal adjacent mucosa was evaluated on Tissue inhibitor of metalloproteinase-3 (TIMP-3) protein tumor to normal mucosa ratio. TIMP-3 protein levels were lower in colorectal cancer than in matched normal mucosa and progressively decreased with advancing tumor stages.
Synapse has enriched 10 related papers. Consider them for comparative context: